| Literature DB >> 30363895 |
Abstract
Wilson's disease (WD) is a potentially fatal disorder of chronic copper toxicity, primarily affecting the liver and the brain. Judicious treatment can restore health and longevity, even in patients with severe neurological impairment. However, the disease is associated with considerable morbidity and mortality resulting from delay in diagnosis, and difficulty in pacing the medical treatment. In this article, we briefly review the diagnosis and treatment options for WD and share our experience in managing patients with WD. We focus on decoppering (copper chelation) treatment of WD and outline pragmatic strategies for patient management designed to recognize and minimize adverse effects while ensuring treatment compliance and effectiveness.Entities:
Keywords: GAS for WD; penicillamine; trientine
Year: 2014 PMID: 30363895 PMCID: PMC6183178 DOI: 10.1002/mdc3.12003
Source DB: PubMed Journal: Mov Disord Clin Pract ISSN: 2330-1619